Instrument Inactif

Autres langues OrganiGram Holdings Inc Toronto S.E.

Actions

CA68620P1018

Installations et services en soins de santé

Autres langues

14/05	Europe’s Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets
12/05	Organigram Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026
12/05	Organigram Global Inc. Updates Revenue Guidance for the Fiscal Year 2026
12/05	Organigram Global Inc. Reports Impairment of Property, Plant and Equipment, Intangible Assets and Goodwill for the Second Quarter Ended March 31, 2026
12/05	Organigram Global : INVESTOR PRESENTATION (dad9ab a7f6d4c8)
12/05	OrganiGram: Fiscal Q2 Earnings Snapshot
12/05	Organigram Global Swings to Q2 Net Loss, Net Revenue Falls; Updates Fiscal 2026 Guidance
12/05	Organigram Global : Press Release (dad9ab a96f5298)
12/05	Earnings Flash (OGI) Organigram Global Inc. Reports Q2 Net Loss $0.9M Vs Net Income of $42.5M in Q2 Fiscal 2025
12/05	Organigram Q2 Adjusted EBITDA $0.9M, Down 82% YoY
12/05	Organigram Q2 Net Revenue $59.8M, Down 9% YoY
12/05	Organigram Reports Second Quarter Fiscal 2026 Results
06/05	Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026
15/04	Organigram Global Inc. announced that it has received CAD 65.200001 million in funding from BT DE Investments Inc.
15/04	Organigram Closes the 107.3-Million Acquisition of Germany's Sanity Group
15/04	Organigram Closes Acquisition of Sanity for $126.6 Million
15/04	Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities
15/04	Organigram Closes Senior Secured Credit Facilities
15/04	Organigram Global Inc. Appoints Max Konrad Narr to the Board of Directors
15/04	Organigram Global Inc. announced that it has received CAD 65.200001 million in funding from BT DE Investments Inc.
15/04	Organigram Global Inc. completed the acquisition of remaining 91% stake in The Sanity Group GmbH from BT DE Investments Inc. and others for approximately ?220 million.
31/03	Organigram Announced Shareholder Approval of Acquisition of Sanity Group GmbH
31/03	Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting
23/03	Organigram Says Proxy Firm ISS Recommends Approval of Sanity Group Acquisition
23/03	Organigram Brief: ISS Citing "Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence" in Recommending Shareholders Vote FOR the Transaction Resolution